Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E T Creagan

Showing results (51-60 of 112) with videos related to

Pageof 12
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1985
Phase II study of a combination of mitomycin, doxorubicin and cisplatin in advanced sarcomasJ H Edmonson, H J Long, R L Richardson, et al.
Cancer|June 1, 1981
Chemotherapy for advanced head and neck cancer with the combination adriamycin, cyclophosphamide, and cis-diamminedichloroplatinum (II): preliminary assessment of a one-day vs. three-day drug regimenE T Creagan, T R Fleming, J H Edmonson, et al.
Mayo Clinic Proceedings|December 1, 1985
Magnetic resonance imaging for neurotoxicity in long-term survivors of carcinomaS Frytak, F Earnest, B P O'Neill, et al.
JAMA|December 6, 1995
Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomasM Weiss, C L Loprinzi, E T Creagan, et al.
Cancer Treatment Reports|November 1, 1981
Phase I and pharmacokinetic studies of DONJ S Kovach, R T Eagan, G Powis, et al.
The New England Journal of Medicine|January 17, 1985
High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparisonC G Moertel, T R Fleming, E T Creagan, et al.
Cancer Treatment Reports|September 1, 1987
Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanomaE T Creagan, D L Ahmann, H J Long, et al.
Cancer Treatment Reports|January 1, 1980
A role of cis-dichlorodiammineplatinum(II) in squamous cell lung cancerR T Eagan, T R Fleming, S Frytak, et al.
Cancer Treatment Reports|May 1, 1986
Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patientsE T Creagan, D L Ahmann, S Frytak, et al.
Medical and Pediatric Oncology|January 1, 1984
Failure of bleomycin to improve the therapeutic effects of a combination of cyclophosphamide, doxorubicin, and cisplatin (CAP) in advanced sarcomasJ H Edmonson, E T Creagan, L K Kvols, et al.
Pageof 12

Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
Cancer Chemotherapy and Pharmacology|January 1, 1985
Phase II study of a combination of mitomycin, doxorubicin and cisplatin in advanced sarcomasJ H Edmonson, H J Long, R L Richardson, et al.
Cancer|June 1, 1981
Chemotherapy for advanced head and neck cancer with the combination adriamycin, cyclophosphamide, and cis-diamminedichloroplatinum (II): preliminary assessment of a one-day vs. three-day drug regimenE T Creagan, T R Fleming, J H Edmonson, et al.
Mayo Clinic Proceedings|December 1, 1985
Magnetic resonance imaging for neurotoxicity in long-term survivors of carcinomaS Frytak, F Earnest, B P O'Neill, et al.
JAMA|December 6, 1995
Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomasM Weiss, C L Loprinzi, E T Creagan, et al.
Cancer Treatment Reports|November 1, 1981
Phase I and pharmacokinetic studies of DONJ S Kovach, R T Eagan, G Powis, et al.
The New England Journal of Medicine|January 17, 1985
High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparisonC G Moertel, T R Fleming, E T Creagan, et al.
Cancer Treatment Reports|September 1, 1987
Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanomaE T Creagan, D L Ahmann, H J Long, et al.
Cancer Treatment Reports|January 1, 1980
A role of cis-dichlorodiammineplatinum(II) in squamous cell lung cancerR T Eagan, T R Fleming, S Frytak, et al.
Cancer Treatment Reports|May 1, 1986
Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patientsE T Creagan, D L Ahmann, S Frytak, et al.
Medical and Pediatric Oncology|January 1, 1984
Failure of bleomycin to improve the therapeutic effects of a combination of cyclophosphamide, doxorubicin, and cisplatin (CAP) in advanced sarcomasJ H Edmonson, E T Creagan, L K Kvols, et al.
Pageof 12